- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Effects of anti-HBs human immunoglobulin for accidental exposures among medical staffs
-
- SAKAMOTO Hisahiro
- Division of Blood Transfusion
-
- SHIMIZU Masaru
- Division of Blood Transfusion
-
- HARADA Hideharu
- Departments of Medicine
-
- OHTAKE Hiroo
- Departments of Medicine
-
- TANAKA Satoshi
- Departments of Medicine
-
- KODAMA Tatsuhiko
- Infectious Disease
-
- OKADA Yoshihiro
- Infectious Disease
-
- KOMACHIYA Kyohei
- Infectious Disease
-
- OHBAYASHI Akira
- Infectious Disease
Bibliographic Information
- Other Title
-
- HBV感染事故に対する抗HBsヒト免疫グロブリンの使用経験
- HBV カンセン ジコ ニ タイスル コウ HBsジン メンエキ グロブリン
Search this article
Description
Forty-one medical staffs accidentally exposed to HBs-antigen positive blood were given anti-HBs human immunoglobulin (HBIG) intramuscularly within 48 hours after exposure. They were followed with tests for HBs antigen, anti-HBs and transaminases in sera at intervals of two weeks for 6 months. Anti-HBc was determined on the sera obtained just before the HBIG injection and the final sera of the follow-up. All the staffs except for one had neither HBs antigen, anti-HBc detected nor transaminases increased in sera during the follow-up periods. Anti-HBs were raised up to 1: 16 to 1: 64 with PHA titer two weeks after the injection of HBIG and disappeared two to three months later.<BR>One of the staffs, a 26 year-old nurse treated with HBIG, acquired acute type B hepatitis 19 weeks after exposure to HBe antigen positive blood. The HBs antigen subtype was identical with that of the source of infection. A similar case was subsequently experienced in a 32year-old female doctor belonging to another hospital. She was exposed to HBe antigen positive blood, and attacked with acute type B hepatitis 30 weeks after exposure in spite of receiving a HBIG injection. These two cases indicate that HBIG might not completely protect the occurrence of acute hepatitis after accidental exposure to HBe positive blood, and that follow-up after the HBIG injection should be continued at least for 9 months, since the incubation time of the acute type B hepatitis would be prolonged.
Journal
-
- Kanzo
-
Kanzo 22 (3), 391-396, 1981
The Japan Society of Hepatology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679767992576
-
- NII Article ID
- 130000877325
-
- NII Book ID
- AN00047770
-
- ISSN
- 18813593
- 04514203
-
- NDL BIB ID
- 2345803
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed